Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer
自我管理以优化肺癌和结直肠癌的生存护理和结果
基本信息
- 批准号:10376753
- 负责人:
- 金额:$ 82.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-02 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
PROJECT SUMMARY
The overarching goal of this five-year grant proposal, submitted on behalf of the Beckman Research Institute of
City of Hope and the University of California, Riverside, in response to RFA-CA-19-035, is to test the efficacy
of an advance-practice nurse (APRN)-driven telehealth Survivor Self-Management (SSM) Intervention in 414
lung and colorectal cancer survivors. This research is critical because lung and colorectal cancer survivors
have high post-treatment needs, are older, and suffers from greater co-morbidities and poor quality of life
(QOL). Lung and colorectal cancer survivors remain underrepresented in research, leading to significant
disparities in post-treatment outcomes. Based on the Chronic Care Self-Management Model (CCM), the SSM
Intervention includes the following components: 1) care coordination and communication between oncology
and primary care on surveillance/follow-up, health promotion, disease prevention, and comorbidity
management; 2) provision of clinician care plan to PCPs; 3) comprehensive patient/geriatric assessment for
survivors of all ages; 4) personalized care plan for survivors; and 5) survivor self-management skills building
for surveillance/follow-up, late and long-term effects of treatments, comorbidities, and healthy living. It is
administered in five telehealth sessions (Zoom videoconferencing) and three subsequent maintenance
telehealth sessions for survivors who are four months post-treatment. We will test the efficacy of the SSM
Intervention using a randomized design of attention control arm versus an intervention arm to pursue the
following specific aims: Specific Aim 1 (Primary): Determine the efficacy of the intervention on care
coordination, communication, and provider knowledge at 4 months post-accrual; Specific Aim 2 (Primary):
Determine the efficacy of the intervention on survivor outcomes at 4 months post-accrual; and Specific Aim 3
(Exploratory): Assess the reach, efficacy, adoption, implementation, and maintenance (RE-AIM) of the
intervention. The RE-AIM Framework informs intervention delivery process, which will set the stage for future
large scale implementation for sustainability in real-world care settings. This proposal is innovative because it
addresses a critical need to improve care delivery and outcomes for high needs, understudied survivorship
populations (lung, colorectal, older survivors), and the telehealth approach promotes scalability. The
interdisciplinary team, which includes expertise in nursing science (Sun, Reb, Ferrell), oncology (Fakih), and
primary care (Kim) is uniquely suited to conduct this research. The proposal is significant, with high scientific
rigor and outcomes that are of critical importance to survivors, clinicians, healthcare systems, the National
Cancer Institute, and the Beau Biden Cancer MoonshotSM. The research will address a critical gap in
knowledge of how self-management interventions improve care delivery and outcomes during post-treatment
transitions to follow-up care.
项目摘要
该五年赠款提案的总体目标是代表贝克曼研究所提交的
希望城市和加利福尼亚大学河滨分校对RFA-CA-19-035的响应是为了测试功效
预先实践护士(APRN)驱动的远程医疗幸存者自我管理(SSM)干预414
肺和结直肠癌幸存者。这项研究至关重要,因为肺和大肠癌幸存者
有很高的治疗需求,年龄较大,患有更大的合并症和生活质量差
(QOL)。肺和结直肠癌幸存者在研究中的代表性不足,导致重要
治疗后结果的差异。基于慢性护理自我管理模型(CCM),SSM
干预包括以下组成部分:1)肿瘤学之间的护理协调和沟通
以及有关监视/随访,健康促进,疾病预防和合并症的初级保健
管理; 2)为PCP提供临床医生护理计划; 3)全面的患者/老年评估
各个年龄段的幸存者; 4)幸存者的个性化护理计划; 5)幸存者自我管理技能建设
用于监视/随访,治疗,合并症和健康生活的晚期和长期影响。这是
在五个远程医疗课程(缩放视频会议)和随后的三个维护中进行管理
治疗后四个月的幸存者的远程医疗会议。我们将测试SSM的功效
使用注意力控制臂的随机设计与干预臂进行干预以追求
以下特定目的:特定目的1(主要):确定干预措施的护理功效
分类后4个月的协调,沟通和提供者知识;特定目标2(主要):
确定分类后4个月对幸存者预后的干预措施的疗效;和特定目标3
(探索性):评估覆盖范围,功效,采用,实施和维护(RE-AIM)
干涉。 RE-AIM框架为干预交付过程提供了信息,这将为将来奠定基础
在现实世界中的护理环境中可持续性的大规模实施。该提议具有创新性,因为它
解决了改善护理交付和满足高需求的结果的关键需求
人群(肺,结直肠,年长的幸存者)和远程医疗方法可促进可扩展性。这
跨学科团队,包括护理科学专业知识(Sun,Reb,Ferrell),肿瘤学(Fakih)和
初级保健(KIM)非常适合进行这项研究。该提议很重要,科学很高
对幸存者,临床医生,医疗保健系统,国家的严格和结果至关重要
癌症研究所和Beau Biden Cancer Moonshotsm。这项研究将解决关键的差距
了解自我管理干预措施如何改善治疗期间的护理交付和结果
过渡到后续护理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
VIRGINIA Chih-Yi S...的其他基金
Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer
自我管理以优化肺癌和结直肠癌的生存护理和结果
- 批准号:1060663510606635
- 财政年份:2020
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
Illness Perception, Pain, and Symptom Distress in Gastrointestinal Cancers
胃肠道癌症的疾病感知、疼痛和症状困扰
- 批准号:76113537611353
- 财政年份:2008
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
Illness Perception, Pain, and Symptom Distress in Gastrointestinal Cancers
胃肠道癌症的疾病感知、疼痛和症状困扰
- 批准号:76955747695574
- 财政年份:2008
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
A Pragmatic Randomized Control Trial of Nurse-Delivered Brief Meaning Centered Psychotherapy for Homebound Palliative Care Patients
护士为居家姑息治疗患者提供简短意义中心心理治疗的实用随机对照试验
- 批准号:1030251110302511
- 财政年份:2021
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
A Pragmatic Randomized Control Trial of Nurse-Delivered Brief Meaning Centered Psychotherapy for Homebound Palliative Care Patients
护士为居家姑息治疗患者提供简短意义中心心理治疗的实用随机对照试验
- 批准号:1047893110478931
- 财政年份:2021
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
Randomized Controlled Trial of Migraine Manager: A Digital Therapeutic Self-Management Tool for Adolescents with Migraine
偏头痛管理器的随机对照试验:偏头痛青少年的数字治疗自我管理工具
- 批准号:1024780510247805
- 财政年份:2020
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
Preventing Prescription Stimulant Diversion and Medication Misuse Via a Web-Based Simulation Intervention
通过基于网络的模拟干预防止处方兴奋剂转移和药物滥用
- 批准号:98954629895462
- 财政年份:2020
- 资助金额:$ 82.17万$ 82.17万
- 项目类别:
Self-Management to Optimize Survivorship Care and Outcomes in Lung and Colorectal Cancer
自我管理以优化肺癌和结直肠癌的生存护理和结果
- 批准号:1060663510606635
- 财政年份:2020
- 资助金额:$ 82.17万$ 82.17万
- 项目类别: